ReviewFederal practitioner : for the health care professionals of the VA, DoD, and PHS2022

Safety Profile of Mutant EGFR-TK Inhibitors in Advanced Non-Small Cell Lung Cancer: A Meta-analysis.

Abubakar Tauseef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.